Sirakoss received CE mark approval for its Osteo3, a new nano-synthetic bone graft substitute designed for use in bone fracture repair.
Three things to know:
1. Based on Sirakoss' proprietary nano-porous technology, Osteo3 consists of an inorganic matrix designed to be completely reabsorbed into the bone.
2. Osteo3 is intended for use as a bone graft material for filling skeletal system voids or gaps. It can be used alone or in combination with autograft or allograft.
3. Sirakoss is a nano-synthetic bone graft substitute developer.